Download presentation
Published byJonas Kendrix Modified over 9 years ago
1
Role of imaging in management of thyroid nodules
Abstract ID – IRIA
2
Investigations Ultrasound – Best modality USG guided FNAC CT MRI
Technetium-99m pertechnetate or 131/123I scintigraphy Ga68 DOTA scintigraphy PET-CT
3
USG descriptors of thyroid nodules
Echogenicity Hyperechoic (> thyroid), Isoechoic (= thyroid), Hypoechoic (< strap muscles) Taller > wide Shape Microcalcification = / < 1mm Calcifications Margin Circumscribed, Microlobulated, Irregular Vascularity Central or peripheral Composition Solid, Cystic, Mixed Radiology. 2011 Sep;260(3):892-9
4
US features of benign nodules
Uniform halo around nodule Enlarged thyroid with multiple nodules Predominantly cystic Avascular Peri-nodular or spoke-and-wheel like appearance of vessels Radiographics May-Jun;27(3):847-60
5
Less specific features
US features of malignant nodules Specific features Less specific features Microcalcifications Markedly hypoechoic Taller than wide in transverse plane Extension beyond thyroid margin Cervical lymph node metastasis No halo around nodule Ill-defined or irregular margin Solid Increased central vascularity Radiographics May-Jun;27(3):847-60
6
1. Calcifications Microcalcifications
Psammoma bodies Common in papillary carcinoma Specificity 86%–95% Positive Predictive Value: 42 – 94 % Inspissated colloid calcifications May mimic microcalcifications Distinguished by ring down/reverberation artefact Coarse calcifications MC in medullary carcinomas May coexist with microcalcifications in papillary cancers Peripheral calcification Most common in MNG Break in peripheral calcification – malignant change in an underlying multinodular goitre Radiographics May-Jun;27(3):847-60
7
2. Margins, contour and shape
Hypoechoic halo highly suggestive of benignity pseudocapsule of fibrous connective tissue or compressed thyroid parenchyma specificity 95% Ill-defined margins > 50% of its border is not clearly demarcated indicate infiltration of adjacent parenchyma sensitivity: 53%– 89% and specificity 7%–97% Hence frank invasion beyond the capsule has to be demonstrated on HPE Shape taller than wide 93% specificity for malignancy Contour Smooth and rounded Irregular/jagged edges Radiographics May-Jun;27(3):847-60
8
3. Echogenicity of the nodule
4. Vascularity Marked intrinsic hypervascularity Flow in the central part of tumour > surrounding thyroid parenchyma Benign nodules Perinodular vascularity – 25% of circumference Complete avascularity is a more useful sign These features are more useful in selecting a nodule for FNAC in multinodular goitre Malignant nodules are solid and hypoechoic Sensitivity 87% but low specificity % Marked hypoechogenicity Darker than strap muscle Specificity 94% Radiographics May-Jun;27(3):847-60
9
5. Local invasion and lymph node metastasis
Features of nodal involvement Rounded bulging shape Increased size Replaced fatty hilum Irregular margins Heterogeneous echotexture Calcifications / Cystic areas Vascularity throughout the lymph node instead of normal central hilar vessels
10
TIRADS - Thyroid image reporting and data system
TIRADS 1 - normal thyroid gland TIRADS 2 - benign lesions TIRADS 3 - probably benign lesions TIRADS 4 - suspicious lesions (4a, 4b, and 4c with increasing risk of malignancy) TIRADS 5 - probably malignant lesions (> 80% risk of malignancy) TIRADS 6 - biopsy proven malignancy J Clin Endocrinol Metab May;94(5):
11
TIRADS 2 – Colloid nodules - 0% risk of malignancy
Avascular anechoic lesion with echogenic specks (colloid type I) Vascular heteroechoic non-expansile, non-encapsulated nodules with peripheral halo (colloid type II) Isoechoic or heteroechoic, non-encapsulated, expansile vascular nodules (colloid type III) Hyperechoic, iso-echoic or hypoechoic nodules, with partially formed capsule and peripheral vascularity <5% risk of malignancy TIRADS 3 J Clin Endocrinol Metab May;94(5):
12
TIRADS 4 & 5 Based on five features: solid component
markedly hypoechoic nodule microlobulations or irregular margins microcalcifications taller-than-wider shape TIRADS 4a - one suspicious feature TIRADS 4b - two suspicious features TIRADS 4c - 3-4 suspicious features TIRADS 5 - all five suspicious features 4a % risk of malignancy 4b & 4c % risk of malignancy 5 - >80% risk of malignancy J Clin Endocrinol Metab May;94(5):
13
Pitfalls on USG - 1. Cystic variant of papillary carcinoma
Cystic component occurs in 13-26% Predominant cystic appearance is rare Can mimic benign cystic hyperplastic nodule Look for Solid components with vascularity Solid excrescences protruding into the cyst Angle of contact by the solid component with the cyst wall Acute – malignancy Obtuse – degenerating cyst (colloid) Microcalcifications RadioGraphics 2007; 27:847–865
14
2. Diffusely infiltrative hypervascular tumour
This variant can be seen in papillary, follicular carcinomas and lymphoma Mimics autoimmune conditions Ex. Graves / thyroiditis De Quervain’s thyroiditis – hypoechoic nodule, may be taller than wide / may have microcalcification Short duration of history of pain Soft on Elastography Look for Echogenicity – markedly hypoechoic History Microcalcifications Case of thyroid lymphoma – markedly hypoechoic and diffusely enlarged thyroid gland in a 62 year old man
15
ELASTOGRAPHY VTI – Virtual Touch Imaging
Objective evaluation of tissue stiffness to differentiate between benign and malignant nodules Sensitivity – 96.3 %; Specificity – 96.2% VTI – Virtual Touch Imaging Reflects the elasticity of tissue with gray-scale image in the field of view (FOV) Dark indicates hard tissue whereas the bright indicates soft tissue VTQ – Virtual Touch Quantification Range for shear wave velocity is 0–9 m/s (beyond this range displayed as “x.xxm/s”) The mean shear wave velocity of VTQ malignant nodules – 3.88 ± 2.24 m/s Benign nodules ± 0.79 m/s Ultrasonography 2014; 33(2): 75-82
16
FNAC CT & MRI CT protocol
Any palpable thyroid nodule if its not TIRADS 2 – FNAC should be done CT & MRI CT protocol Non-contrast Thin slice thickness – mm Axial, coronal & sagittal planes Neck & thorax (MC & AC – include liver) Inferior to ultrasound in diagnosing thyroid cancer Main role is in staging Intravenous iodinated contrast agents interfere with the 131/123I uptake for at least 1–3 months Advantage of MRI avoids the use of iodinated contrast agents Very specific in showing tracheal, oesophageal and recurrent laryngeal nerve invasion
17
CT preferred Calcification Retrosternal region Extent Metastasis
Mediastinal nodes
18
Ga68 DOTA PET/CT Thyroid scintigraphy
Somatostatin analogs labelled with Ga 68 High affinity for Somatostatin receptors SSTR expressed – neurons & endocrine cells Thyroid – medullary carcinoma To localize an inconclusive nodule Staging Recurrence Treatment response Medullary carcinoma Thyroid scintigraphy Indications whole body scan for distant metastases estimation of local residual thyroid post thyroidectomy follow-up for tumour recurrence Cold – 85% of nodules are cold, hence not used to diagnose malignancy
19
Imaging for post-op, pre-radiotherapy planning and surveillance
FDG-PET Imaging in distant metastases 131I – treatment of functioning thyroid cancer & imaging of functioning metastases Ga68 DOTA PET/CT Bone scan / scintigraphy – bone metastases CT / MRI – if needed High negative predictive value Incidental focal uptake in thyroid Specific USG features 80 % malignant Imaging for post-op, pre-radiotherapy planning and surveillance To look for residual / recurrence of primary tumour & nodal involvement Routinely done with ultrasound; CT / MRI – no significant role Yearly ultrasound of the neck +/− FNA for surveillance of disease-free patients PC/FC - normal thyroglobulin (Tg > 50 ng/mL – functioning metastases after complete ablation of thyroid tissue) Cancer imaging.2008;8(1):57-59
20
Conclusion Ultrasound plays a major role differentiating benign & malignant nodules Specific features: markedly reduced echogenicity microcalcifications taller than wide local invasion lymph node metastases Histopathological examination – confirmatory Recent advances – Elastography increases the positive predictive value when combined with conventional ultrasound
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.